Pain relieving capacity of combined femoral and sciatic nerve block with help of ultrasound using dexamethasone(steroid) as an additive to levobupivacaine(local anesthetic) versus levobupivacaine alone in foot and ankle surgeries: A randomized controlled clinical study
Recruiting
- Conditions
- Medical and Surgical, (2) ICD-10 Condition: M968||Other intraoperative and postprocedural complications and disorders of musculoskeletal system, not elsewhere classified,
- Registration Number
- CTRI/2023/03/050243
- Lead Sponsor
- All India Institute of Medical Sciences, Bhubaneswar
- Brief Summary
The primary purpose of this study is to estimate the duration of analgesia and effective surgical anesthesia provided by levobupivacaine and combination of levobupivacaine and dexamethasone when used for femoral and sciatic nerve block for foot and ankle surgeries of trauma.
The hypothesis is dexamethasone provides a longer duration of analgesia and patient satisfaction when used as an adjuvant to levobupivacaine for ultrasound-guided femoral and sciatic nerve block.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
- Patients of trauma scheduled for unilateral foot and ankle surgery 2.
- Patients with ASA (American Society of Anesthesiologists) grade I-II.
Exclusion Criteria
- Uncontrolled Diabetes Mellitus 2.
- Allergy to local anesthetics 3.
- Coagulopathy 4.
- Pregnancy 5.
- Skin infection at the injection site 6.
- Haemodynamically unstable patients.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To estimate the duration of analgesia (time to first rescue analgesia)in both the groups Within 24 hours
- Secondary Outcome Measures
Name Time Method 1.To determine the onset time and duration of sensory and motor block 1. Within 24 hours
Trial Locations
- Locations (1)
AIIMS Bhubaneswar
🇮🇳Khordha, ORISSA, India
AIIMS Bhubaneswar🇮🇳Khordha, ORISSA, IndiaDr Ajitesh SahuPrincipal investigator8826727889sahu.ajitesh84@gmail.com